Invitation to Bid for medicines and related products for the treatment Drug Sensitive forms of TB
18 October 2016 - Geneva, Switzerland - On behalf of Stop TB Partnership’s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF-contracted procurement agent, invites all eligible suppliers to submit a bid for medicines and related products for the treatment of Drug Sensitive forms of TB as described in this Invitation to Bid (ITB).
The purpose of this ITB is to select a panel of suppliers who will enter into a long-term agreement with IDA to supply the First Line Anti-TB medicines (FLDs) and related products as specified in this ITB document.
This ITB is open to bidders whose products have been deemed eligible for inclusion in the tender in compliance with GDF's Quality Assurance policy and procedures.
Deadline for electronic submission of Technical and Financial Bids: 16 November 2016 at 16.00 hours IST (India Standard Time).
Faxed or proposals sent through courier are not acceptable.
Public opening of the Financial Bids will take place at IDA Foundation’s Mumbai office on 23 November 2016 at 10.00 IST (India Standard Time).